NO991465L - FremgangsmÕter og preparater for lipidisering av hydrofile molekyler - Google Patents

FremgangsmÕter og preparater for lipidisering av hydrofile molekyler

Info

Publication number
NO991465L
NO991465L NO991465A NO991465A NO991465L NO 991465 L NO991465 L NO 991465L NO 991465 A NO991465 A NO 991465A NO 991465 A NO991465 A NO 991465A NO 991465 L NO991465 L NO 991465L
Authority
NO
Norway
Prior art keywords
lipidization
preparations
methods
hydrophilic molecules
hydrophilic
Prior art date
Application number
NO991465A
Other languages
English (en)
Other versions
NO991465D0 (no
Inventor
Wei-Chiang Shen
Jinghua Wang
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of NO991465D0 publication Critical patent/NO991465D0/no
Publication of NO991465L publication Critical patent/NO991465L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542Carboxylic acids, e.g. a fatty acid or an amino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO991465A 1996-09-26 1999-03-25 FremgangsmÕter og preparater for lipidisering av hydrofile molekyler NO991465L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72130696A 1996-09-26 1996-09-26
US4949997P 1997-06-13 1997-06-13
PCT/US1997/017282 WO1998013007A2 (en) 1996-09-26 1997-09-26 Methods and compositions for lipidization of hydrophilic molecules

Publications (2)

Publication Number Publication Date
NO991465D0 NO991465D0 (no) 1999-03-25
NO991465L true NO991465L (no) 1999-05-10

Family

ID=26727231

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991465A NO991465L (no) 1996-09-26 1999-03-25 FremgangsmÕter og preparater for lipidisering av hydrofile molekyler

Country Status (10)

Country Link
EP (1) EP1023316A4 (no)
JP (1) JP2002515883A (no)
KR (1) KR100691315B1 (no)
CN (1) CN1127477C (no)
AU (1) AU737865B2 (no)
BR (1) BR9712128A (no)
CA (1) CA2267179A1 (no)
IL (1) IL129177A0 (no)
NO (1) NO991465L (no)
WO (1) WO1998013007A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169078B1 (en) * 1998-05-12 2001-01-02 University Of Florida Materials and methods for the intracellular delivery of substances
TWI242000B (en) * 1998-12-10 2005-10-21 Univ Southern California Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use
GB0103877D0 (en) * 2001-02-16 2001-04-04 King S College London Novel Drug Delivery system
US20050054612A1 (en) * 2003-09-08 2005-03-10 Monahan Sean D. Delivery by labile hydrophobic modification of drugs
CA2551131A1 (en) * 2003-12-31 2005-07-21 Centocor, Inc. Novel recombinant proteins with n-terminal free thiol
WO2008057298A2 (en) * 2006-10-27 2008-05-15 Wei-Chiang Shen Lipidized interferon and uses thereof
WO2008109119A2 (en) * 2007-03-05 2008-09-12 The Board Of Trustees Of The Leland Stanford Junior University Wnt compositions and methods of use thereof
CA2716255C (en) * 2008-02-21 2016-11-29 Dermacare Neuroscience Institute Cosmetic and dermatological formulations of mntf peptides
CN105283441B (zh) * 2013-02-28 2018-10-23 塔夫茨大学 用于递送药剂的二硫化合物
US20160082126A1 (en) * 2013-05-13 2016-03-24 Tufts University Nanocomplexes for delivery of saporin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5907030A (en) * 1995-01-25 1999-05-25 University Of Southern California Method and compositions for lipidization of hydrophilic molecules
BR9709993A (pt) * 1996-06-25 1999-08-10 Stichting Inst Dierhouderij Vacina preparação de vacina composição processo para produção de uma preparação imugênica e preparação imugênica

Also Published As

Publication number Publication date
CN1127477C (zh) 2003-11-12
WO1998013007A2 (en) 1998-04-02
AU737865B2 (en) 2001-09-06
CN1235594A (zh) 1999-11-17
EP1023316A4 (en) 2004-06-09
WO1998013007A8 (en) 1999-05-20
KR100691315B1 (ko) 2007-03-12
BR9712128A (pt) 2000-12-12
KR20000048608A (ko) 2000-07-25
EP1023316A2 (en) 2000-08-02
AU4596797A (en) 1998-04-17
NO991465D0 (no) 1999-03-25
CA2267179A1 (en) 1998-04-02
IL129177A0 (en) 2000-02-17
JP2002515883A (ja) 2002-05-28

Similar Documents

Publication Publication Date Title
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
NO972125D0 (no) Hemmoroideblandinger og fremgangsmåte for anvendelse
DK0873189T3 (da) Adsorptionsmedium og fremgangsmåde til fremstilling deraf
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
NO974365L (no) Fremgangsmåte og krystallformer av 2-metyl-thieno-benzodiazepin
IT1278961B1 (it) Procedimento e sistema di aferesi
NO974572D0 (no) Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav
NO971015D0 (no) Forbindelser og metoder for behandling av cancer
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
DK0906029T3 (da) Isoflavonberiget sojaproteinprodukt og fremgangsmåde til fremstilling heraf
NO970532D0 (no) System og metode for blodbehandling
DK0850948T3 (da) Propiophenonderivater og fremgangsmåde til fremstilling deraf
NO980687D0 (no) System og fremgangsmåte for perfusjon-hypertermibehandling
DK0729951T3 (da) Naphthylforbindelser, mellemprodukter, præparater og fremgangsmåder
NO991493D0 (no) FremgangsmÕte for forbedret selektivitet i fotoaktivering og deteksjon av molekylµre diagnostiske midler
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
DK0863856T3 (da) Komposteringssystem og fremgangsmåde
NO974500L (no) Blandinger og fremgangsmåter for inhibering av trombogenese
NO991382L (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
NO971710L (no) Fremgangsmåte for inversjon av seismiske data
DK0889690T3 (da) Antibiotisk cocktail og fremgangsmåde til anvendelsen
NO991465D0 (no) FremgangsmÕter og preparater for lipidisering av hydrofile molekyler
DE69714504D1 (de) Benzothiopene, diese enthaltende Zubereitungen und Verfahren
NO971505D0 (no) Trofinin og trofininhjelperproteiner
DK0826679T3 (da) Naphthylforbindelser og -præparater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application